SCHEMBL7780795

SCHEMBL7780795

CN(C)CCn1cc(-c2ccccc2)c(-c2ccc(S(N)(=O)=O)cc2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 8/20 0.52
CA1 P00915 11/20 0.49
CA2 P00918 11/20 0.49
CA9 Q16790 11/20 0.49
PTGIR P43119 1/20 0.47
CA12 O43570 7/20 0.45
BRAF P15056 1/20 0.42
MAPK3 P27361 1/20 0.42
MAPK1 P28482 1/20 0.42
PTGS1 P23219 3/20 0.42
MT-CO2 P00403 1/20 0.42
LMNA P02545 1/20 0.42
CA3 P07451 1/20 0.42
ADRB2 P07550 1/20 0.42
ADRB1 P08588 1/20 0.42
CYP3A4 P08684 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CHRM1 P11229 1/20 0.42
ADRA2B P18089 1/20 0.42
CA4 P22748 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779613 0.91 CA9 (0.45) PTGS2CA1CA2CA9CA12
SCHEMBL7777697 0.90 PTGS2 (0.46) PTGS2CA1CA2CA9CA12
SCHEMBL7772845 0.90 PTGS2 (0.56) PTGS2CA1CA2CA9CA12
SCHEMBL7780590 0.89 PTGS2 (0.64) PTGS2PTGIRBRAFMAPK3MAPK1
SCHEMBL7780139 0.88 MEN1 (0.58) PTGS2CA1CA2CA9CA12
SCHEMBL8629705 0.85 PTGIR (0.43) PTGS2CA1CA2CA9PTGIR
SCHEMBL7773166 0.84 PTGIR (0.56) PTGS2CA1CA2CA9PTGIR
SCHEMBL7780667 0.84 PTGS2 (0.51) PTGS2CA1CA2CA9PTGIR
SCHEMBL7772854 0.83 PTGS2 (0.45) PTGS2CA1CA2BRAFMAPK3
SCHEMBL8758730 0.82 PTGS2 (0.56) PTGS2PTGIRBRAFMAPK3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed